Wave Life Sciences Ltd. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Wave Life Sciences Ltd. (WVE), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are WVE insiders buying or selling?
Wave Life Sciences Ltd. insiders reported 8 open-market buys ($133.8M) and 70 sells ($29.6M) across 78 Form 4 filings — a net buying position of $104.2M.
Source: SEC EDGAR Form 4
Key Statistics (as of Mar 31, 2026)
Insider sentiment
Net buyingNet insider flow of $104.2M in net buying.
Recent WVE insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Peter Kolchinsky | Director, 10% Owner | Purchase | 8.8M | $6.23 | $54.6M |
| Feb 28, 2026 | Chris Francis | SVP, Corporate Development, Head of Emerging Areas | Sale | 33.2K | $15.05 | $499.6K |
| Feb 12, 2026 | Kyle Moran | Chief Financial Officer | Sale | 3.6K | $13.45 | $48.3K |
| Feb 12, 2026 | Paul Bolno | President and CEO | Sale | 10.5K | $13.45 | $141.0K |
| Feb 12, 2026 | Chris Francis | SVP, Corporate Development, Head of Emerging Areas | Sale | 1.9K | $13.45 | $25.3K |
| Feb 12, 2026 | Chandra Vargeese | Chief Technology Officer, Head of Platform Discovery Sciences | Sale | 3.2K | $13.45 | $43.4K |
| Jan 7, 2026 | Chris Francis | SVP, Corporate Development, Head of Emerging Areas | Sale | 9.4K | $16.03 | $150.3K |
| Nov 15, 2025 | Adrian Rawcliffe | Director | Sale | 16.1K | $6.79 | $109.4K |
| Nov 14, 2025 | Peter Kolchinsky | Director, 10% Owner | Purchase | 1.0K | $6.69 | $6.7K |
| Aug 27, 2025 | Gregory L. Verdine | Director | Sale | 10.0K | $10.00 | $100.0K |
| Aug 27, 2025 | Paul Bolno | President and CEO | Sale | 217.4K | $10.10 | $2.2M |
| Aug 20, 2025 | Aik Na Tan | Director | Sale | 21.0K | $9.25 | $194.3K |
| Aug 14, 2025 | Christian O Henry | Director | Sale | 9.7K | $8.81 | $85.2K |
| Aug 8, 2025 | Ken Takanashi | Director | Sale | 4.9K | $8.75 | $42.6K |
| Aug 8, 2025 | Aik Na Tan | Director | Sale | 1.1K | $8.75 | $9.9K |
| Jun 14, 2025 | Gregory L. Verdine | Director | Sale | 30.0K | $6.95 | $208.5K |
| Mar 22, 2025 | Christian O Henry | Director | Sale | 10.5K | $9.77 | $102.6K |
| Mar 8, 2025 | Paul Bolno | President and CEO | Sale | 169.0K | $9.57 | $1.6M |
| Nov 28, 2024 | Paul Bolno | President and CEO | Sale | 50.0K | $15.00 | $750.0K |
| Nov 16, 2024 | Paul Bolno | President and CEO | Sale | 51.2K | $14.32 | $733.7K |
| Nov 14, 2024 | Chris Francis | SVP, Corporate Development, Head of Emerging Areas | Sale | 36.0K | $16.00 | $576.0K |
| Oct 19, 2024 | Chris Francis | SVP, Corporate Development, Head of Emerging Areas | Sale | 208.8K | $13.67 | $2.9M |
| Oct 19, 2024 | Paul Bolno | President and CEO | Sale | 90.5K | $15.00 | $1.4M |
| Oct 1, 2024 | GSK plc | 10% Owner | Purchase | 2.8M | $8.00 | $22.3M |
| Sep 28, 2024 | Kyle Moran | Chief Financial Officer | Sale | 17.1K | $9.00 | $154.3K |
Showing the 25 most recent of 78 Form 4 filings for Wave Life Sciences Ltd..
Most active WVE insiders
- Paul Bolno19 filings
- Chris Francis14 filings
- Chandra Vargeese9 filings
- Kyle Moran8 filings
- Michael A. Panzara7 filings
Ask anything about WVE insider activity
Use Trabud's AI agent to query Wave Life Sciences Ltd.'s Form 4 history in plain English — "Show me WVE CEO purchases this year" or compare it against any other ticker.
Open the AI agentWVE insider trading FAQ
Are Wave Life Sciences Ltd. insiders buying or selling?
Across 78 SEC Form 4 filings, Wave Life Sciences Ltd. (WVE) insiders reported 8 open-market purchases totaling $133.8M and 70 sales totaling $29.6M. That is a net buying position of $104.2M.
How many insiders trade WVE stock?
14 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Wave Life Sciences Ltd.. The most recent filing was accepted on Mar 31, 2026.
Where does Trabud get WVE insider trading data?
All WVE insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.